Aditya Birla Sun Life Small Cap Fund

Aditya Birla Sun Life Small Cap Fund has delivered a 10Y SIP XIRR of 15.9% and a 5Y SIP XIRR of 17.34%, consistently underperforming the category average SIP XIRR, which stands at 20.81% and 22.84% for the same periods. However, on a lump-sum basis the fund has tracked its benchmark closely, with a 5Y fund CAGR of 12.11% versus 12.09% for the NIFTY SmallCap 250, while generating a meaningful 1Y alpha of 11.05% (fund CAGR 8.06% vs benchmark -3.72%). Recent relative performance is strong, with consistent positive alpha over the 1Y, 3Y, 12Y, and 15Y horizons.

The fund has a low beta of 0.85-0.93 across horizons and a downside capture consistently below 88%, indicating it falls less than the benchmark in downturns. Risk-adjusted quality is evidenced by alpha at nearly every horizon and a 1Y Calmar ratio of 0.379, though drawdown behavior shows 7 events exceeding 10% and a lengthy 799-day maximum drawdown period with a 380-day recovery, reflecting the inherent volatility of the small-cap segment. Calendar year returns are highly dispersed, ranging from -21.8% in 2018 to 67.29% in 2014, confirming significant year-to-year volatility.

The portfolio is well diversified across 87 stocks, with the top holding at just 2.83% (SAI Life Sciences) and the top ten collectively at roughly 22.6% of NAV, showing no single-stock concentration risk. Sector exposure is spread across pharmaceuticals (9.3%), banks (8.9%), auto components (7.5%), finance (6.7%), and consumer durables (6.5%), blending defensives with financials and cyclicals. The holdings mix, including names like Navin Fluorine, TD Power Systems, and Radico Khaitan, reflects a quality-oriented, multi-sector small-cap approach.

While the fund's lump-sum CAGR has broadly matched its benchmark, its SIP XIRR at 15.9% over 10Y, 5Y, and 7Y horizons trails the category average SIP XIRR of 20.81%, 22.84%, and 21.77% respectively, placing it in the lower half of small-cap peers on SIP returns. Its consistency advantage lies in downside protection, with downside capture of 85.08% over 1Y and 87.09% over 10Y, cushioning losses relative to the index. The strong recent 1Y alpha of 11.05% suggests improving relative positioning versus the benchmark.

This fund suits investors seeking small-cap exposure with moderato downside behavior rather than maximum upside aggression, given its sub-90% upside and downside capture profile. A long horizon of at least 7-10 years is advisable, as small-cap drawdowns here have lasted up to 799 days and returns swing widely between years. Investors should have a high risk tolerance and treat this as a satellite allocation within a diversified equity portfolio.

• Consistent positive alpha versus the NIFTY SmallCap 250 across most horizons, including 11.05% over 1Y and 2.62% over 12Y
• Low downside capture (83-88%) and beta below 0.93, indicating better loss protection than the benchmark during declines
• Well-diversified portfolio of 87 holdings with the largest stock at just 2.83% of NAV and no dominant sector concentration

• SIP XIRR lags the category average by roughly 3-5 percentage points across 3Y, 5Y, 7Y, and 10Y horizons, indicating below-peer SIP returns
• High return dispersion with calendar-year swings from -21.8% (2018) to 67.29% (2014), plus a maximum drawdown period of 799 days that tests investor patience